| Abstrakt: |
Background: Carcinoma of the floor of the mouth (FOM) can be difficult to treat surgically. Reconstruction is often necessary to close defects and restore function. In countries with limited resources, the pedicled pectoralis major myocutaneous (PMMC) flap can be considered as an alternative for FOM reconstruction, especially in the era of microvascular techniques. Methods: In this study, we assess the effectiveness of using the PMMC flap to treat defects caused by carcinomas in the floor of the mouth (FOM). We have analyzed 28 patients and examined the surgical techniques, postoperative results, and complications related to the use of the PMMC flap. We have compared this approach to other reconstruction methods, with a focus on restoring function and ensuring patient satisfaction. Results: In our research, we studied 28 patients who had the floor of mouth cancer. Out of them, 15 patients underwent PMMC flap reconstruction. The reconstruction results were encouraging as patients reported high satisfaction levels with improved speech and swallowing abilities. Although some complications were observed, such as two cases of orocutaneous fistula formation and one case of partial flap necrosis, the functional outcomes of PMMC flap reconstruction were better than other flap reconstructions. Conclusions: In modern times, reconstructive surgery has advanced significantly, and the PMMC flap has proven its enduring worth. Although it may not always be the first choice, this time-tested technique has emerged as a viable option in the armamentarium for FOM carcinoma reconstruction. By balancing tradition and innovation, surgeons are able to offer optimal outcomes, functional restoration, and patient satisfaction in this challenging clinical scenario. Therefore, the PMMC flap deserves consideration as a valuable adjunct in the modern era of microvascular reconstruction for floor-of-mouth carcinoma. Further research and case studies are necessary to refine its indications and techniques in contemporary practice. Level of Evidence: Level IV, therapeutic study. [ABSTRACT FROM AUTHOR] |
Full text from SpringerLink